Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.74 Bn | 86.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.87 Bn | 32.13 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.28 Bn | 30.34 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | -28.01% |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - | - |
| 7 | Viatris | 20.25 Bn | 18.44 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.89 Bn | 16.57 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 41.72% |
| 10 | Ironwood Pharmaceuticals | 629.29 Mn | 408.82 Mn | - | -41.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.35% |
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | -41.60% |
| Jun 30, 2025 | -40.09% |
| Mar 31, 2025 | -28.99% |
| Dec 31, 2024 | -30.63% |
| Sep 30, 2024 | -31.07% |
| Jun 30, 2024 | -26.50% |
| Mar 31, 2024 | -36.50% |
| Dec 31, 2023 | -49.38% |
| Sep 30, 2023 | -12.86% |
| Jun 30, 2023 | -411.32% |
| Mar 31, 2023 | 177.99% |
| Dec 31, 2022 | -250.38% |
| Sep 30, 2022 | 92.48% |
| Jun 30, 2022 | 122.54% |
| Mar 31, 2022 | 151.97% |
| Dec 31, 2021 | 31.71% |
| Sep 30, 2021 | 36.40% |
| Jun 30, 2021 | 115.27% |